AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 282: H1197-H1205, 2002. First published November 29, 2001; doi:10.1152/ajpheart.00483.2001
0363-6135/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/H1197    most recent
00483.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cox, M. J.
Right arrow Articles by Tyagi, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cox, M. J.
Right arrow Articles by Tyagi, S. C.
Vol. 282, Issue 4, H1197-H1205, April 2002

Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats

Michael J. Cox1, Harpreet S. Sood1, Matthew J. Hunt1, Derrick Chandler1, Jeffrey R. Henegar2, Giorgio M. Aru3, and Suresh C. Tyagi1

1 Department of Physiology and Biophysics, 2 Department of Pathology, and 3 Department of Cardiothoracic Surgery, School of Medicine, University of Mississippi Medical Center, Jackson, Mississippi 39216

The hypothesis is that chronic increases in left ventricular (LV) load induce oxidative stress and latent matrix metalloproteinase (MMP) is activated, allowing the heart to dilate in the absence of endothelial nitric oxide (NO) and thereby reduce filling pressure. To create volume overload, an arteriovenous (A-V) fistula was placed in male Sprague-Dawley rats. To decrease oxidative stress and apoptosis, 0.08 mg/ml nicotinamide (Nic) was administered in drinking water 2 days before surgery. The rats were divided into the following groups: 1) A-V fistula, 2) A-V fistula + Nic, 3) sham operated, 4) sham + Nic, and 5) control (unoperated); n = 6 rats/group. After 4 wk, hemodynamic parameters were measured in anesthetized rats. The heart was removed and weighed, and LV tissue homogeneates were prepared. A-V fistula caused an increase in heart weight, lung weight, and end-diastolic pressure compared with the sham group. The levels of malondialdehyde (MDA; a marker of oxidative stress) was 6.60 ± 0.23 ng/mg protein and NO was 6.87 ± 1.21 nmol/l in the LV of A-V fistula rats by spectrophometry. Nic treatment increased NO to 13.88 ± 2.5 nmol/l and decreased MDA to 3.54 ± 0.34 ng/mg protein (P = 0.005). Zymographic levels of MMP-2 were increased, as were protein levels of nitrotyrosine and collagen fragments by Western blot analysis. The inhibition of oxidative stress by Nic decreased nitrotyrosine content and MMP activity. The levels of tissue inhibitor of metalloproteinase-4 mRNA were decreased in A-V fistula rats and increased in A-V fistula rats treated with Nic by Northern blot analysis. TdT-mediated dUTP nick-end labeling-positive cells were increased in A-V fistula rats and decreased in fistula rats treated with Nic. Acetylcholine and nitroprusside responses in cardiac rings prepared from the above groups of rats suggest impaired endothelial-dependent cardiac relaxation. Treatment with Nic improves cardiac relaxation. The results suggest that an increase in the oxidative stress and generation of nitrotyrosine are, in part, responsible for the activation of metalloproteinase and decreased endocardial endothelial function in chronic LV volume overload.

nitric oxide; malondialdehyde; collagen degradation; tissue inhibitor of metalloproteinase; arteriovenous fistula; nicotinamide; NADH oxidase; nitrotyrosine; TUNEL; cardiac ring; acetylcholine; nitroprusside; stretch; contraction; relaxation; heart failure


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. E. Rodriguez, I. G. Joshua, J. C. Falcone, and S. C. Tyagi
Pioglitazone prevents cardiac remodeling in high-fat, high-calorie-induced Type 2 diabetes mellitus
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H81 - H87.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. V. Ovechkin, N. Tyagi, W. E. Rodriguez, M. R. Hayden, K. S. Moshal, and S. C. Tyagi
Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice
J Appl Physiol, December 1, 2005; 99(6): 2398 - 2405.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. S. Moshal, N. Tyagi, B. Henderson, A. V. Ovechkin, and S. C. Tyagi
Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2770 - H2777.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. L. Lindsey, D. K. Goshorn, C. E. Squires, G. P. Escobar, J. W. Hendrick, J. T. Mingoia, S. E. Sweterlitsch, and F. G. Spinale
Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function
Cardiovasc Res, May 1, 2005; 66(2): 410 - 419.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. S. Ikonomidis, J. W. Hendrick, A. M. Parkhurst, A. R. Herron, P. G. Escobar, K. B. Dowdy, R. E. Stroud, E. Hapke, M. R. Zile, and F. G. Spinale
Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H149 - H158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Husse, A. Sopart, and G. Isenberg
Cyclical mechanical stretch-induced apoptosis in myocytes from young rats but necrosis in myocytes from old rats
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1521 - H1527.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. C. Tyagi and B. D. Hoit
Metalloproteinase in Myocardial Adaptation and Maladaptation
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2002; 7(4): 241 - 246.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online